Catalyst Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$148K Buy
2016
Q1
Sell
2015
Q4
$94K Sell
2015
Q3
$884K Sell
2015
Q2
$15.6M Sell
2015
Q1
$20.9M Buy